During the past decade, Good Samaritan Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 33 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Good Samaritan Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 34 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Good Samaritan Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Good Samaritan Cancer Center" are "Breast Cancer" (19 trials), "Lung Cancer" (11 trials), "Prostate Cancer" (9 trials), "Lymphoma" (7 trials) and "Metastatic Cancer" (4 trials). Many other conditions were trialed in "Good Samaritan Cancer Center" in a lesser frequency.

Most popular intervention types in "Good Samaritan Cancer Center" are "Drug" (42 trials), "Other" (20 trials), "Biological" (16 trials), "Procedure" (9 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (12 trials), "placebo" (9 trials), "docetaxel" (6 trials), "biologic sample preservation procedure" (5 trials) and "cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Good Samaritan Cancer Center" are 35 trials for "All" genders, 17 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Good Samaritan Cancer Center". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Good Samaritan Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Good Samaritan Cancer Center, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".